CFO4Life Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,913
Closed -$559K 231
2025
Q1
$559K Buy
+7,913
New +$559K 0.09% 113